Microdosing, which involves starting with significantly lower doses (0.1mg to 0.25mg), aims to mitigate these adverse effects, making the therapy more tolerable for a broader range of patients
Ibrahim Mohammed, [email protected] This article was submitted to Endocrinology of Aging, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Personal or family history of medullary thyroid carcinoma (MTC) GLP-1 receptor agonists carry a boxed warning related to thyroid C-cell tumors observed in animal studies
About the Author: Edison de Mello, MD, PhD, the author of Bloated: How to Eat Without Pain is an integrative physician, researcher, and educator specializing in functional and metabolic medicine
More than expected